ABSTRACT
Objectives Post-stroke depression (PSD) is a common complication after stroke. To date, no consistent locus of injury is associated with this complication. Here, we probed network dynamics in four functional circuits tightly linked to major depressive disorder and investigated structural alterations within these networks in PSD.
Methods Forty-four participants with recent stroke and 16 healthy volunteers were imaged with 3T structural, diffusion and resting-state functional MRI and completed the Geriatric Depression Scale (GDS). Associations between GDS and functional connectivity were investigated within networks seeded from nucleus accumbens (NAc), amygdala and dorsolateral prefrontal cortex. In addition, the default mode network (DMN) was identified by connectivity with medial prefrontal cortex (mPFC) and posterior cingulate cortex (PCC). Circuits that exhibited altered activity associated with GDS were further investigated by extracting within-network volumetric and microstructural measures from structural images.
Results Functional connectivity within the NAc-seeded network and DMN correlated positively with depressive symptoms. Normal anticorrelations between these two networks were absent in patients with PSD. PCC grey matter volume as well as microstructural measures in mPFC and the medial forebrain bundle, a major projection pathway interconnecting the NAc-seeded network and links to mPFC, were associated with GDS scores.
Conclusions Depression after stroke is marked by reduced mutual inhibition between functional circuits involving NAc and DMN as well as volumetric and microstructural changes within these networks. Aberrant network dynamics present in patients with PSD are therefore likely to be influenced by secondary, pervasive alterations in grey and white matter, remote from the site of injury.
Competing Interest Statement
MJO has received support to attend meetings from Boehringer Ingelheim and received honoraria for consultancy from EMVison Medical Devices Ltd, Australia. The other authors declare no competing financial interests.
Funding Statement
This study was funded by the Medical Research Council, UK (grant reference MR/K022113/1) and the European Commission Horizon 2020 Health Programme (CoSTREAM, grant agreement 667375).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the London and Bromley Research Ethics Committee (REC reference: 13-LO-1745) and the University of Queensland Research Ethics Committee (Clearance number: 2018001541).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors